Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Amer Sports $1.2 billion credit facilities and €700 million credit facility
We advised the borrowers on the financing transactions
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Texas Instruments $3 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
MSCI acquisition of Foxberry
We are advising MSCI on the acquisition
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Truist sale of Sterling Capital Management to Guardian Capital
We are advising Truist on the transaction
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Morgan Stanley Bank $2 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Immatics $201 million follow-on offering
We advised Immatics on the offering of shares